These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33968032)

  • 1. The NLRP3-Inflammasome-Caspase-1 Pathway Is Upregulated in Idiopathic Pulmonary Fibrosis and Acute Exacerbations and Is Inducible by Apoptotic A549 Cells.
    Jäger B; Seeliger B; Terwolbeck O; Warnecke G; Welte T; Müller M; Bode C; Prasse A
    Front Immunol; 2021; 12():642855. PubMed ID: 33968032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRP3 inflammasome activation contributes to the development of the pro-fibrotic phenotype of lung fibroblasts.
    Nguyen TH; Nguyen HH; Nguyen TD; Tran VT; Nguyen HA; Pham DV
    Biochem Pharmacol; 2024 Aug; 229():116496. PubMed ID: 39159876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional Chinese medicine inspired dual-drugs loaded inhalable nano-therapeutics alleviated idiopathic pulmonary fibrosis by targeting early inflammation and late fibrosis.
    Zheng M; Liu K; Li L; Feng C; Wu G
    J Nanobiotechnology; 2024 Jan; 22(1):14. PubMed ID: 38166847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.
    Molyneaux PL; Cox MJ; Wells AU; Kim HC; Ji W; Cookson WO; Moffatt MF; Kim DS; Maher TM
    Respir Res; 2017 Feb; 18(1):29. PubMed ID: 28143484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF3 aggravates acute exacerbation of pulmonary fibrosis by disrupting alveolar epithelial barrier integrity.
    Guo B; Liu W; Ji X; Xi B; Meng X; Xie W; Sun Y; Zhang M; Liu P; Zhang W; Yan X; Chen B
    Int Immunopharmacol; 2024 Jun; 135():112322. PubMed ID: 38788452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review.
    Luppi F; Cerri S; Taddei S; Ferrara G; Cottin V
    Intern Emerg Med; 2015 Jun; 10(4):401-11. PubMed ID: 25672832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-Like Receptor 9 Aggravates Pulmonary Fibrosis by Promoting NLRP3-Mediated Pyroptosis of Alveolar Epithelial Cells.
    Ren C; Wang Q; Fan S; Mi T; Zhang Z; He D
    Inflammation; 2024 Mar; ():. PubMed ID: 38498270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elamipretide(SS-31) Attenuates Idiopathic Pulmonary Fibrosis by Inhibiting the Nrf2-Dependent NLRP3 Inflammasome in Macrophages.
    Nie Y; Li J; Zhai X; Wang Z; Wang J; Wu Y; Zhao P; Yan G
    Antioxidants (Basel); 2023 Nov; 12(12):. PubMed ID: 38136142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of acute exacerbation of pulmonary fibrosis.
    Ye X; Zhang M; Gu H; Liu M; Zhao Y; Shi Y; Wu S; Jiang C; Ye X; Zhu H; Li Q; Huang X; Cao M
    Respir Res; 2023 Nov; 24(1):296. PubMed ID: 38007420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 and cancer: Pathogenesis and therapeutic opportunities.
    Tengesdal IW; Dinarello CA; Marchetti C
    Pharmacol Ther; 2023 Nov; 251():108545. PubMed ID: 37866732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.
    Kulkarni T; Criner GJ; Kass DJ; Rosas IO; Scholand MB; Dilling DF; Summer R; Duncan SR
    BMC Pulm Med; 2024 Mar; 24(1):143. PubMed ID: 38509495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis.
    Konishi K; Gibson KF; Lindell KO; Richards TJ; Zhang Y; Dhir R; Bisceglia M; Gilbert S; Yousem SA; Song JW; Kim DS; Kaminski N
    Am J Respir Crit Care Med; 2009 Jul; 180(2):167-75. PubMed ID: 19363140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.
    Kulkarni T; Criner GJ; Kass DJ; Rosas IO; Scholand MB; Dilling DF; Summer R; Duncan SR
    Res Sq; 2024 Feb; ():. PubMed ID: 38464052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors associated with mortality in acute exacerbations of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
    Pitre T; Lupas D; Ebeido I; Colak A; Modi M; Kachkovski GV; Montesi SB; Khor YH; Kawano-Dourado L; Jenkins G; Fisher JH; Shapera S; Rochwerg B; Couban R; Zeraatkar D
    Respir Med; 2024 Feb; 222():107515. PubMed ID: 38154738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Proposal.
    Johannson K; Collard HR
    Curr Respir Care Rep; 2013 Dec; 2(4):. PubMed ID: 24416637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitigation of Oxidative Stress in Idiopathic Pulmonary Fibrosis Through Exosome-Mediated Therapies.
    Wang Z; Zhang Y; Li X
    Int J Nanomedicine; 2024; 19():6161-6176. PubMed ID: 38911503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis.
    Zhou Y; Ling T; Shi W
    Respir Res; 2024 Jun; 25(1):245. PubMed ID: 38886743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials.
    Sgalla G; Lerede M; Richeldi L
    Expert Opin Emerg Drugs; 2021 Jun; 26(2):93-101. PubMed ID: 33998354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial.
    Martinez FJ; Yow E; Flaherty KR; Snyder LD; Durheim MT; Wisniewski SR; Sciurba FC; Raghu G; Brooks MM; Kim DY; Dilling DF; Criner GJ; Kim H; Belloli EA; Nambiar AM; Scholand MB; Anstrom KJ; Noth I;
    JAMA; 2021 May; 325(18):1841-1851. PubMed ID: 33974018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Signatures of Idiopathic Pulmonary Fibrosis.
    Konigsberg IR; Borie R; Walts AD; Cardwell J; Rojas M; Metzger F; Hauck SM; Fingerlin TE; Yang IV; Schwartz DA
    Am J Respir Cell Mol Biol; 2021 Oct; 65(4):430-441. PubMed ID: 34038697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.